Horizon Therapeutics plc Named to Newsweek’s List of the Most Loved Workplaces for 2021
“At Horizon, our employees are at the heart of what we do which is why we are especially honored to be named to Newsweek’s Most Loved Workplaces,” said
Produced in collaboration with the Best Practice Institute (BPI), a leadership development and benchmark research company, the Newsweek list results were determined after surveying more than 800,000 employees from businesses with workforces varying in size from 50 to more than 10,000. Companies were also evaluated by external public ratings from sites such as Comparably, Careerbliss, Glassdoor, Indeed and Google, and from direct interviews with and written responses from company officials. Newsweek then conducted additional research into every company on the list, as well as the top runners up, to determine the final list of 100 companies and their ranking.
“In the wake of the pandemic, business hit hurdles in terms of retaining and attracting employees – but the companies that made this list are delivering the respect, care, and appreciation that it takes to create a positive workplace that nurtures talent,” said
The full Newsweek list of 2021’s Most Loved Workplaces will be featured in the magazine’s
About Newsweek
Newsweek is the modern global digital news organization built around the iconic, over 85-year-old
About
Best Practice Institute is an award-winning leadership and organization development center, benchmark research company, think tank, and solutions provider. BPI is the certifying body for Most Loved Workplace® and conducted the original research to create the model and criteria for becoming a Most Loved Workplace®. BPI’s research proves that Most Loved Workplaces produce 3-4 times better customer service, employee performance, and retention than companies not loved by their employees.
About Horizon
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211022005288/en/
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com
Ireland Media Contact:
Gordon MRM
ray@gordonmrm.ie
Source: